임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
35건 표시
- 1상모집 중· Surgical Wound InfectionA Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
협력: 노보노디스크
- 1상모집 중단 (진행 중)· OverweightA Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
리드: 노보노디스크
- 1상모집 중· Healthy VolunteersA Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM
리드: 노보노디스크
- 1상모집 중· Diabetes MellitusInvestigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
리드: 노보노디스크
- 1상모집 중· Transthyretin Amyloid CardiomyopathyA Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.
리드: 노보노디스크
- 1상모집 중· Healthy VolunteerA Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
리드: 노보노디스크
- 1상모집 중· Heart FailureA Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
리드: 노보노디스크
- 1상모집 중· ObesitySafety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
리드: 노보노디스크
- 1상모집 중단 (진행 중)· Diabetes Mellitus, Type 1A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
리드: 노보노디스크
- 1상모집 중· Healthy VolunteersMultiple Dose Study for a New Medication to Potentially Treat Liver Diseases
리드: 노보노디스크
- 1상모집 중· Healthy VolunteersA Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
리드: 노보노디스크
- 1상모집 중단 (진행 중)· ObesityA Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
리드: 노보노디스크
- 1상모집 중· Solid Tumors, AdultSafety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
리드: 노보노디스크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.